ReviewCancer diagnosis & prognosis
Prognostic Significance of Lymphatic Vessel Invasion and Density in Colorectal Carcinoma: A Systematic Review and Meta-analysis.
Review in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analysis of Formimidoyltransferase Cyclodeaminase as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.Cancer genomics & proteomicsArticle
- Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression.Cancer genomics & proteomicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: This systematic review and meta-analysis evaluated the relationship between lymphatic vessel invasion (LVI) and lymphatic vessel density (LVD) - with specific focus on distinguishing peritumoral from intratumoral LVD, assessed by immunohistochemistry - and survival outcomes in patients with colorectal carcinoma (CRC). Materials and Methods: Following Cochrane Handbook and PRISMA guidelines, we included original studies evaluating tumor LVD and/or LVI in colorectal cancer using immunohistochemistry and reporting hazard ratios for overall survival (OS) and/or disease/recurrence-free survival (DFS). Data from MEDLINE, Cochrane Library, and PubMed (past 25 years) were extracted, analyzed with Stata, and assessed for heterogeneity and publication bias. Results: The principal results of the present study were the statistically significant correlations between a) LVI and reduced OS ( Conclusion: LVI and LVD parameters (peritumoral, intratumoral, total), evaluated using immunohistochemistry, may provide valuable information with respect to the prognosis of patients with CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.